|
13.00-14.30pm, Wednesday 8th February 2012
Stavros Petrou, Professor of Health Economics at the Warwick Medical School, University of Warwick, UK
Should health gains by children be given the same value as health gains by adults in an economic evaluation framework?
Summary: Economic evaluations that measure the benefits of health interventions in terms of QALYs gained inevitably require decision-makers to make judgments about the ‘value for money’ of those health gains. Decision-making bodies, such as the National Institute for Health and Clinical Excellence in England and Wales, have commonly returned to the position that an additional QALY is of equal value regardless of the characteristics of the recipient, such as their socio-demographic characteristics or their pre- or post-treatment levels of health. Any move away from this uniform-weighted cost-per-QALY approach should have a strong theoretical and empirical basis. This presentation will focus on whether units of health gain should be given the same value for children as for adults in an economic evaluation framework. The theoretical arguments in favour of age weights for units of health gain, such as QALYs, will be outlined. These include productivity ageism, the idea that health gain at different ages should be valued differently according to the expected level of productivity of each individual at each age, and ‘fair innings’ ageism, the idea that there is some amount of quality-adjusted length of life that can be regarded as an ethical entitlement for everybody. Existing empirical evidence will be presented from a number of revealed preference and stated preference studies that suggest that individuals tend to place greater weight upon health gains by children, although a number of limitations of these studies will also be highlighted. Finally, the presentation will summarise the results of a recently-completed empirical study that builds on the previous UK Social Value of a QALY (SVQ) study to address this normative question. The study surveyed a sample (n=2500) of the UK population using ‘matching’ (or ‘person trade-off’) questions. It is anticipated that the results of this relativities study will feed into the decision-making processes of bodies such as the National Institute for Health and Clinical Excellence.
Format of seminars:
The seminars form a key part in disseminating research findings and play an important part in contributing to the Health Economics Research Groups activity. The seminars usually take place on the first Tuesday of each month, starting at 4.00pm in the seminar room in the Gaskell building. The guest speaker has an opportunity to present a topic of their choice for approximately 45 minutes and then it is open to the floor for discussion. Guests are invited to join HERG for a glass of wine after the seminar.
Examples of previous seminars:
11 January 2012
'Innovation' in health care: All talk and no substance?
Professor Stirling Bryan from University of British Columbia
1st November 2011
CEA and Multiple Sclerosis: how we do CEA, and some findings from the South-West Impact of Multiple Sclerosis (SWIMS) Study Professor Colin Green from University of Exeter (Peninsula Medical School)
6th September 2011, 4pm
Methods to estimate the cost-effectiveness threshold for the NHS
Professor Mark Sculpher, Centre for Health Economics, University of York
Click here to download the presentation.
5th April 2011, 4pm
Stated preference measurement: a case study of the treatment of chronic pain
Methodological issues in the economic evaluation of medical technologies using observational data
Dimitrios Rovithis, National Perinatal Epidemiology Unit, University of Oxford
7th September 2010, 4pm
A new economic model for COPD
Helen Starkie, NICE
Tuesday, 15th June 2010, 4pm
Title: Not all incentives wash out the ‘warm glow’: The case of Blood Donation revisited
Dr Mireia Jofre-Bonet, City University
Tuesday, 11th May 2010, 4pm
Title: Does Private Practice Affect the Quality of Services Provided by Public Sector Doctors? (joint work with Menno Pradhan, University of Amsterdam and World Bank)
Sarmistha Pal, Department of Economics and Finance, Brunel University
Tuesday, 13th April 2010, 4pm
Title: The right tool for the job? Using dynamic modelling techniques to model unconventional diseases
James Jarrett, Research Associate, School of Medicine, Health Policy and Practice, University of East Anglia
Tuesday, 2nd March 2010, 4pm
Title: The design of clinical and economic evaluations in complex areas of health and social care: the case of child and adolescent mental health services
Sarah Byford, Senior Lecturer, Centre for the Economics of Mental Health, Institute of Psychiatry
Tuesday, 2nd February 2010, 4pm
Title: The Count Data Stochastic Frontier with an Application
Eduardo Fe-Rodriguez, Research Fellow, Health Methodology Research Group, University of Manchester
Monday, 18th January 2010, 4pm
Title: The VPF-QALY Relationship and End-of-Life Treatment: Should there be a Pure Value of Life
Shepley Orr, Senior Research Fellow, Department of Civil, Environmental and Geomatic Engineering, and Centre for Philosophy, Justice and Health, University College London
7th December 2009, 4pm
Title: Vignettes and health systems responsiveness in cross country comparative analyses
Silvana Robone, Research Fellow, Health Econometrics and Data Group (HEDG), University of York
Monday 5th October 2009
Title: Family income and child cognitive and behavioural development in the United Kingdom: does money matter?
Mara Violato, Health Economics Research Centre (HERC), University of Oxford
Monday 7th September 2009
Title: Is depression in parents associated with high Negative Expressed Emotion towards their child?
Lamprini Psychogiou, University of Oxford
Monday 1st June 2009
Title: Can Public Service Organisations influence quality of life?
Adriana Castelli, Centre for Health Economics, University of York
Monday 5th May 2009
Title: Using Rasch Analysis in the Development of Preference-Based Measures
Tracey Young, ScHARR, University of Sheffield
Tuesday 6th May 2008
Title: How can NICE improve the way it creates guidance in public health? An economic perspective
Alastair Fischer, NICE and St George's, University of London
Monday 3rd December 2007
Title: Model averaging for handling uncertainty in decision models
Christopher Jackson, MRC Biostatistics Unit, Cambridge
Monday 5th November 2007
Title: Cost effective diagnosis
Joanne Lord, National Institute for Health and Clinical Excellence (NICE)
Monday 1st October 2007
Title: A framework for modelling and presenting the cost-effectiveness of adjuvant systemic therapy for women with early breast cancer
Helen Campbell, Health Economics Research Centre,
University of
Oxford
Monday 14th May 2007
Title: Estimating pharmaceutical companies' value to the national economy - case study of the British Pharma Group
Martina Garau, Office of Health Economics, London
Monday 16th April 2007
Title: Alternative approaches to valuing health states for use in economic evaluation: an investigation of validity and reliability
Suzanne Robinson , HSMC, University of Birmingham
Monday 26th March 2007
Title: Estimating Health State Valuation Models From Ordinal Health State Preference Data (Rank And Discrete Choice Experiments)
John Brazier, School of Health and Related Research, University of Sheffield
Monday 5th March 2007
Title: Incorporating "psychological" outcomes into cost-effectiveness analysis
Gerry Richardson, CHE, University of York
Monday 6th November 2006
|
|
